Pancreatic Cancer Research

ResearcherCharles UniversityActive in the last 2 years

Miroslav Zavoral

Matched on ORCID iD 0000-0001-7883-7431; OpenAlex author ID A5035344671. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 6)
Trials
0
Grants
0
Labs led
2
Collaborators
16
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: 3 papers · 2017: 3 papers · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 14

  1. Prevalence of new onset diabetes mellitus among patients with pancreatic ductal adenocarcinoma: a population-based study Co-author DOI 10.64898/2026.08.05.26359758↗
  2. Prognostic Role of Specific KRAS Mutations Detected in Aspiration and Liquid Biopsies from Patients with Pancreatic Cancer. Co-author DOI 10.3390/genes15101302↗
  3. Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. Last author DOI 10.3390/cancers15143669↗
  4. Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Testing in Pancreatic Cancer. Co-author DOI 10.1007/s12253-018-0490-9↗
  5. Chiroptical spectroscopy and metabolomics for blood-based sensing of pancreatic cancer. Co-author DOI 10.1002/chir.22834↗
  6. Precursors of pancreatic cancer. Last author DOI 10.1097/meg.0000000000000810↗
  7. Early detection of sporadic pancreatic cancer: time for change. Last author DOI 10.1097/meg.0000000000000904↗
  8. [Diagnosis of early pancreatic cancer and precursor lesions]. Co-author PMID 29063770↗
  9. Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2016.06.001↗
  10. Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkers. Last author DOI 10.1097/meg.0000000000000727↗
  11. [Early detection of sporadic pancreatic cancer]. Last author PMID 26898791↗
  12. [Pancreatic adenocarcinoma - early symptoms and screening]. Last author PMID 25561240↗
  13. Early diagnosis of pancreatic adenocarcinoma: role of stroma, surface proteases, and glucose-homeostatic agents. First author DOI 10.1097/mpa.0b013e31823b5827↗
  14. Molecular biology of pancreatic cancer. Co-author DOI 10.3748/wjg.v17.i24.2897↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bohuš Bunganič · 10 shared papers, 2014–2024 · strength 1.05
  2. Jan Škrha · 7 shared papers, 2016–2026 · strength 0.78
  3. Jan Bureš · 2 shared papers, 2023–2026 · strength 0.46
  4. Premysl Fric · 7 shared papers, 2012–2017 · strength 0.45
  5. Tereza Hálková · 2 shared papers, 2020–2024 · strength 0.38
  6. Marek Minárik · 2 shared papers, 2020–2024 · strength 0.38
  7. Lucie Benešová · 2 shared papers, 2020–2024 · strength 0.38
  8. Pavel Škrha · 4 shared papers, 2016–2023 · strength 0.38
  9. Aleksi Šedo · 5 shared papers, 2016–2017 · strength 0.31
  10. Petr Bušek · 5 shared papers, 2016–2017 · strength 0.31
  11. Ondřej Májek · 1 shared paper, 2026 · strength 0.27
  12. Lucie Habartová · 2 shared papers, 2017–2018 · strength 0.17
  13. Vladimı́r Setnička · 2 shared papers, 2017–2018 · strength 0.17
  14. Tomáš Zima · 2 shared papers, 2016 · strength 0.11
  15. Martina Hrůzová · 1 shared paper, 2017 · strength 0.08
  16. Pavel Záruba · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.